Bringing Discoveries to Commercialization
Allinaire Therapeutics, a new Biotechnology Start-Up, Launches to Combat Lung Diseases

Events

Allinaire Therapeutics, a new Biotechnology Start-Up, Launches to Combat Lung Diseases

Wednesday, January 4, 2017

Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. Allinaire Therapeutics is based on discoveries and intellectual property from the Indiana University School of Medicine, developed by scientific founders Irina Petrache, MD and Matthias Clauss, PhD. Dr. Petrache is currently the Chief of Pulmonary, Critical Care, and Sleep Medicine at National Jewish Health in Denver, and Dr. Clauss is the Associate Research Professor of Cellular & Integrative Physiology at Indiana University.  [Allinaire – Press Release]